Jun 19, 2019 4:04pm EDT DiaMedica Therapeutics Announces Interim Results from Phase 1b Trial of DM199 in Chronic Kidney Disease Participants
May 22, 2019 9:30am EDT DiaMedica Therapeutics to Present at the 16th Annual Craig-Hallum Institutional Investor Conference on May 29, 2019
May 21, 2019 8:34am EDT DiaMedica Therapeutics Announces Formation of Scientific Advisory Board for Kidney Disease
May 13, 2019 4:48pm EDT DiaMedica Therapeutics Announces First Quarter 2019 Financial Results and Provides Business Update
May 06, 2019 8:54am EDT DiaMedica Therapeutics to Report First Quarter 2019 Financials and Provide an Update on Development Programs on May 14, 2019
Mar 19, 2019 4:30pm EDT DiaMedica Therapeutics Announces 2018 Financial Results and Provides Corporate Update
Mar 18, 2019 1:56pm EDT DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call
Mar 12, 2019 1:00pm EDT DiaMedica Therapeutics to Attend 31st Annual ROTH Investor Conference on March 18-19, 2019
Feb 14, 2019 7:00am EST DiaMedica Therapeutics Doses First Patient in Phase 1b Clinical Study of DM199 in Patients with Chronic Kidney Disease
